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ABStrACt 
Introduction: The study of placentas from pregnant human immunodeficiency virus (HIV) positive women has become the subject of 
numerous studies in the literature. Morphological, viral, immune and inflammatory placental aspects have been analyzed in order to 
grasp the vertical transmission of the virus. Objective: To identify the most frequent findings in the placentas by associating them with 
a viral antigen and correlating them with the infection of newborns. Material and methods: Thirty-five placentas from HIV- positive 
pregnant women were pathologically and immunohistochemically analyzed with the use of p24 antibody in the period from 1992 to1997 
in accordance with the routine laboratory testing from the Anatomopathological Department - Hospital Universitário Antônio Pedro - 
Universidade Federal Fluminense (APD/HUAP/UFF). Results: The microscopic alterations detected in all cases, including those with 
vertical transmission, were arteriopathy in the fetal blood circulation, chorioamnionitis, perivillous fibrin deposition, syncytial knotting, 
villous edema and villous immaturity. No specific macroscopic or histopathological changes were found in these placentas. The neonatal 
infection was observed in five cases. Vertical transmission was identified in two out of five placentas that had low weight for the respective 
stage of pregnancy. Immunohistochemical analysis revealed 14 positive cases, two of which showed vertical transmission. The viral protein 
was not identified in 10 out of 14 placentas from patients who had been medicated with zidovudine (AZT). Conclusion: Our study has 
contributed to the anatomopathological investigation into placentas from HIV-positive patients, although p24 expression per se did not 
allow a definite and early diagnosis of the vertical transmission
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introDuCtion
The vertical transmission of the human immunodeficiency 
virus (HIV) has been widely studied and particular emphasis has 
been given to the role of the placenta as a selective membrane of 
the mother-infant pair and prime source of congenital infection.
Transplacental infection has evolved with the adoption of 
obstetric (cesarean section) and pharmacological (antiretrovirals 
during gestation, delivery and puerperium) practices, inasmuch 
as  less than a decade ago 14% to 48% of the concepti from infected 
mothers acquired the infection(27), whereas currently this total 
dropped to 1% to 2%(17).
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The use of zidovudine (AZT) has been proven to be 
unequivocally effective in reducing vertical transmission of 
HIV. However, in order to yield the best results, these patients 
should be advised not to breastfeed. Moreover, AZT oral 
solution should be administered to the newborn for six weeks 
after delivery. These children must be assessed by specialized 
units until their diagnosis is defined. Their serology should 
be performed monthly for the first six months and at least 
quarterly from the second semester until the 18th week. If 
there is no evidence of HIV-positive results, the child will be 
considered uninfected. This process usually causes anguish 
and uncertainty among relatives, hence the need for tests that 
can allow an early diagnosis of transplacental transmission of 
HIV. Nevertheless, the mechanisms of transplacental infection 
by HIV as well as the details pertaining to the perinatal 
transmission are still unclear.
The placentas from HIV-infected patients are usually normal 
and show no specific histological changes that could be attributed 
to HIV contamination, which differs from other congenital 
transplacental viral infections(4). Nonetheless, chorioamnionitis 
and villous immaturity with hypercellularity of villous stroma have 
been frequently reported(25), hence requiring further investigation 
into possible histopathological effects of placental infection by 
HIV. Some morphological findings such as placentitis, mainly 
chorioamnionitis and funisitis are referred to as risk factors for 
vertical transmission(7, 21).
Furthermore, we have striven to identify the presence of HIV 
in the human placenta through the use of more sophisticated 
diagnostic procedures. Some authors use a variety of techniques 
such as electron microscopy (12), immunohistochemistry(16), in 
situ hybridization(7) and polymerase chain reaction(18). They 
have also identified the virus preference for Hofbauer cells 
rather than trophoblasts and endothelial cells. One of the 
targets for the diagnosis of viral infection is p24, which is a 
protein of 24 kilodaltons present in the HIV nucleocapsid. 
However, paradoxically, the mere presence of the virus in the 
placenta did not correlate with the vertical transmission of HIV. 
Conversely, some cases of congenital infection were observed 
without the presence of the virus, hence the need for further 
investigation into the role of the viral presence in the vertical 
HIV infection(9).
Thus, the objective of the present study is to correlate the 
morphology and p24 immunoreactivity in placentas from HIV-
positive pregnant women  with the vertical transmission in 
patients that had been treated or not with prophylactic AZT during 
pregnancy or delivery.
MAtEriAL AnD MEthoDS
We conducted a prospective study with pregnant patients 
followed at Antonio Pedro University Hospital, Universidade 
Federal Fluminense (APUH/UFF), in the period of 1992 to 1997. 
The pregnant women included in this investigation met the 
following criteria: two results for enzyme-linked immunosorbent 
assay (ELISA) and one positive result for HIV Western blot, delivery 
at APUH/UFF with more than 32 weeks of gestation, pediatric 
follow-up with ELISA anti-HIV in the first six months of life 
monthly and quarterly until the 18th week of life(19). Patients 
younger than 18 years of age, those who had been in treatment for 
acquired immunodeficiency syndrome (AIDS) and those who did 
not fulfill the complete follow-up criteria were excluded from this 
research protocol.
We analyzed 35 HIV-infected pregnant women without prior 
antiretroviral treatment who were medicated with AZT during 
pregnancy and intrapartum. After delivery, their placentas 
were placed in vials with 10% buffered formalin and sent to the 
Pathology Service (PS). The anatomopathological analysis was 
conducted by the same pathologist. The macroscopic study of 
the placentas was performed according to the protocol proposed 
by Benirschke & Kaufmann(5). The tissue samples were fixed in 
10% buffered formalin for subsequent paraffin embedding and 
standard histological processing. 4 μm histological sections were 
obtained from the paraffin block and stained with hematoxylin 
and eosin (HE), which were examined and the histopathological 
diagnoses were recorded. In the immunohistochemical study, HIV 
p24 antigen was used as primary antibody (clone Kal-1, Dako, 
code M857, Batch 062), adopting the Avidin - Biotin - Peroxidase 
method(13).
The following clinical variables were analyzed: patient’s age, 
gestational age at delivery, associated obstetric complications, 
type of delivery, indication for cesarean delivery and vertical 
transmission of HIV (assessed up to 18 months after delivery). 
We also described the morphological variables of the placenta 
(weight in grams, chorionic plate diameter, thickness, umbilical 
cord length and color of the maternal and fetal sides as well as 
Wharton’s jelly) and p24 immunoreactivity in different cells from 
the placental parenchyma. Statistical analysis was carried out and 
mean/median, ranges, standard deviation (SD) and percentage 
were calculated according to the variable type. We employed 
a nonparametric corrected X2 (chi-square) test. The level of 
significance was set at p < 0.05.
This study was approved by the Ethics in Research from APUH/
UFF. 
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The median age of patients was 25 years (ranges: 19-37; SD 
= 4.3 years). The mean gestational age at delivery was 38 weeks 
(ranges: 33-40; SD = 1.4 weeks).
Obstetric complications occurred in 22/35 (62.8%) patients: 
urinary tract infection and prematurity in seven patients each 
(7/35-20%); genital condylomata (6/35-17%); syphilis, tuberculosis, 
genital candidiasis and premature amniorrhexis in three patients 
each (3/35-8.5%); pulmonary pneumocystosis, hepatitis B, genital 
trichomoniasis, placental abruption, cord prolapse and prolonged 
amniorrhexis in one patient each (1/35-2.8%).
Cesarean section was performed in 80% of patients 
(28/35) with the following indications: elective (18/28-64.2%), 
prematurity (7/28-25%), prolapsed umbilical cord (1/28-3.4%), 
chorioamnionitis by prolonged amniorrhexis (1/28-3.4%) and 
acute fetal distress - placental abruption with live fetus (1/28-
3.4%). Vaginal delivery occurred in 20% of patients (7/35), all 
admitted to the maternity hospital in advanced labor (active 
phase, with more than 7 cm dilation, fetal head fixed in the pelvis). 
2 out of 5 patients who had their children infected by HIV had 
preterm delivery, one with placental abruption and acute fetal 
distress. All presented ascending infection (chorioamnionitis) and 
two of them had other associated infections.
Regarding placental morphology, the macroscopic study 
revealed that the weight of the 28 placentas from full term 
pregnancies averaged 466.6 g (ranges: 200-862; SD = 65 g), 
whereas the weight of the seven preterm placentas averaged 372 
g (extremes: 215-530; SD = 32g). 78.5% (22/28) of the placentas 
from full term pregnancies had suitable weight for the gestational 
age (between 10th and 90th percentile), whereas 14.2% (4/28) of 
them were considered small for the gestational age (below  the 
10th percentile) and 7.1% (2/28) were large for the gestational age 
(above the 90th percentile). 57% of the preterm placentas (4/7) 
had suitable weight for the gestational age (between the 10th and 
90th percentile), whereas 33% (3/7) were small for the gestational 
age (below the 10th percentile), with no cases of large placenta for 
the gestational age in this group. The diameter of the placental 
chorionic plate measured 18.2 cm on average (ranges: 13.5-27.5; 
SD = 0.4 cm). The thickness of the placentas was on average 2 cm 
(ranges: 3.5-1.0; SD = 0.4 cm). The length of the umbilical cord 
measured 31.6 cm on average (ranges: 18-68; SD = 8 cm).
Vertical transmission of HIV was observed in two neonates 
(2/5-40%) whose placentas had low weight for the gestational age 
among the seven placentas with low weight from a total of 35 cases 
(7/35-20%).
The chorion laeve was transparent in most placentas (26/35-
74%) and opalescent in 9 /35 (26%). The coloring of the Wharton’s 
jelly was predominantly white (28/35-80%), although it also 
presented other hues: yellow (3/35-8.8%), violet (2/35-5.6%), green 
(1/35-2.8) and pink (1/35- 2.8%). The fetal side was described as 
predominantly bluish (32/35- 91.5%) and in a few cases greenish 
(3/35-7.5%). The fetal side of the amnion was transparent in 
23/35 (65.5%) and opalescent in 12 /35 (34.5%) placentas. On the 
maternal side, the lobes were well defined in 25/35 (71.5%) and 
poorly defined in 10/35 (28.5%) placentas. Sectioning revealed 
that the tissue was spongy, wine-red (29/35-82.8%) and light red 
(6/35-17.2%), with calcifications (11/35-31.5%), infarcts (10/35-
28.5%) and retroplacental hematoma (1/35-2.8%), whereas 13 
sections revealed no morphological changes (13/35-37.2%). As 
far as microscopy is concerned, those five placentas with vertical 
transmission presented slightly opalescent chorion indicating 
chorioamnionitis. Subsequently, the diagnosis was confirmed by 
microscopy.
The incidence of placental microscopic lesions observed in 
35 placentas and in the five placentas from children who had 
acquired HIV infection by vertical transmission are shown in 
Figure 1.
figurE 1 – The growing incidence of microscopic findings of 35 placentas from 
HIV-positive patients and the incidence of findings in the group of five children with 
concomitant HIV infection
HIV: human immunodeficiency virus.
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The microscopic study indicated that all placentas were 
from the third trimester of pregnancy, including the premature 
ones. The fetoplacental vasculopathy was the most common 
histopathological finding, which was observed in 33/35 (94.2%) 
placentas. This change was characterized by thickening of the 
vascular walls due to an endothelial edema extending from the 
subendothelial layer to the middle and adventitial layers as well 
as hyperplasia of the middle layer and occasionally perivascular 
fibrosis with consequent reduction of the vascular lumen 
(Figure 2). Vasculopathy was present in all five cases of fetal 
infection. Chorioamnionitis was the second most frequent 31/35 
(88.6%), present in all cases in which there was fetal infection. 
Villous immaturity (Figure 3) characterized by stromal villous 
hypercellularity was the third most frequent infection observed in 
30/35 (85.7%) HIV + placentas, which was present in all cases of 
vertical transmission.
Immunohistochemistry showed positivity for p24 antigen in 
14/35 (40%) cases. The following results were yielded: five positive 
cases in the cells and endothelium of the decidua reflexa vessels; 
four cases in  decidua basalis cells;  three cases in lymphocytes 
from the intervillous space; one case in trophoblasts; four cases in 
Hofbauer cells from the villous stroma; one case in lymphocytes 
from the lumen of a blood vessel in the villous branch. The 
immunopositivity occurred in six patients in different locations of 
the same placenta (Figures 4 and 5).
figurE 2 – Microscopy (HE): arteriopathy – wall thickening  with edema, 
hyperplasia of the middle layer and lumen reduction . 40 × / 0.65
HE: hematoxylin and eosin.
figurE 4 – p24 IHC : Positive immunostaining in Hoffbauer cells from the 
villous stroma and in  trophoblasts . 40 × / 0.65
IHC: immunohistochemistry.
figurE 3 – Microscopy (HE): immaturity - villous stromal hypercellularity. 
40 × / 0.65
HE: hematoxylin and eosin.
figurE 5 – p24 IHC: positive immunostaining in the decidua and trophoblasts. 
40 × / 0.65
IHC: immunohistochemistry.
From a total of 14 placentas that showed immunopositivity for 
p24 antigen, seven newborns were not infected, five had no clinical 
follow-up and two were infected presenting immunostaining for p24 
in trophoblasts and Hofbauer cells. From the total of 21 cases with 
negative immunohistochemistry, three newborns acquired infection, 
eight were not infected and ten had no follow-up (Table 1).
From a total of 14 placentas from patients treated with AZT, the 
immunohistochemistry confirmed positivity for the viral protein 
Anatomopathological characterization of placentas from HIV+ patients associated with p24 expression
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in 4 cases (28.5%), involving basal decidua cells and lymphocytes 
from the intervillous space. In the other 21 placentas from patients 
not treated with AZT, p24 antigen was detected in 10 cases (52.3%) 
(Table 2).
From a total of 14 patients treated with AZT, the prophylaxis 
was efficient in five neonates, two children were infected and seven 
of them had no follow-up records. From a total of 21 patients who 
were not treated with AZT, ten were not infected, three were infected 
and eight of them had no clinical follow-up (Table 3).
HIV and vice versa, insofar as the child was infected and the viral 
antigen was not detected in placental tissue. Baurakiades et al.(4) 
demonstrated by histomorphometry that in placentas from HIV-
positive pregnant women the villi were smaller in comparison with 
seronegative patients. Furthermore, the immunohistochemistry 
revealed that anti-p24 antibody presented lower immunostaining 
(2 / 57) to detect the viral protein, but they observed CD8 T cells 
and the intercellular adhesion molecule (ICAM-1) as biological 
markers of inflammatory placental changes associated with 
HIV-1 infection. The positivity for the viral protein was detected 
in all 57 cases by  polymerase chain reaction (PCR), a genomic 
amplification method.
Although the exact mechanisms of vertical transmission 
remain unclear, some authors such as Moussa et al.(18) 
applied PCR to detect placental cytokines such as macrophage 
inflammatory proteins (MIP) 1α, MIP-1β, interleukin (IL) -8 
and IL-6 in HIV + patients. They observed a reduction of these 
substances in their sample, thus the newborns were not infected. 
The study by Vidricaire, Tardif and Tremblay(30) revealed an 
increase in the tumor necrosis factor alpha (TNF-α) and IL-1 in 
placentas of HIV + patients and correlated the inflammation of 
placental tissue, namely chorioamnionitis and chronic villitis, 
with HIV vertical transmission. Bento et al.(6) and Pornprasert et 
al.(22) developed  comparative studies with pregnant women who 
had a controlled or uncontrolled viral load and showed a rise 
in the secretion of IL-10 cytokine by T cells in the first group 
of patients, which caused a decrease in viral replication, hence 
influencing the reduction of vertical transmission. Scarlatti(24) 
studied the advances and disputable aspects of HIV-1 vertical 
transmission and reported that research into the role of viral 
characteristics, immune response and genomic polymorphisms 
of the host have not always produced final results. Even viral 
strains that are involved in the vertical transmission, namely 
those that use CCR5 receptor, may undergo mutations that may 
not be transferred, especially during the perinatal transmission. 
Derrien et al.(11) and Faye et al.(12) investigated the role of the 
placenta in vertical transmission and suggested that placental 
cells such as trophoblasts, Hofbauer cells and the villous 
capillary endothelial cells have CD4 positive receptors, which 
makes them susceptible to HIV infection. Moreover, they revealed 
that placental cytokines (TNF-α and IL-8) and chemokines 
(regulated on activation, normal T cell expressed and secreted [ 
RANTES ] and MIP-1β) are modulators through their receptors 
in order to prevent viral replication of HIV and to induce it. In the 
same study, from the genetic analysis of the HIV-1 sequencing, 
the interaction of certain genotypic viral characteristics with 
placental tissue was observed. Therefore, vertical transmission of 
tABLE 1 – Correlation between p24 viral  
rotein and vertical transmission
p24 Infected Non-infected
Positive 2 (14%) 7 (50%)
Negative 3 (12%) 8 (38%)
Total 5 (14%) 15 (43%)
X2 = 0.49; p > 0.05 non-significant. The remaining 15 children from our sample 
had no outpatient follow-up. 
tABLE 3 – Correlation between the use of AZT 
 in pregnant women and vertical transmission
Vertical transmission
Use of AZT Infected Non-infected
Yes 2 (14%) 5 (36%)
No 3 (14%) 10 (50%)
AZT: zidovudine.
X2 = 0.49; p > 0.005 non-significant. It was not possible to verify infection 
prophylaxis in 15 children who had no outpatient follow-up. 
tABLE 2 – Correlation between the use of AZT in  
pregnant women and p24 viral protein in placentas.
p24
Use of AZT Presence Absence
Number  
of cases
Yes 4 (28%)      10 (72%) 14 (100%)
No 10 (50%)    11  (50%)    21 (100%)
Total 14 (40%)    21  (60%)    35 (100%)
AZT: zidovudine.
X2 = 1.26; p > 0.005 non-significant. It was not possible to verify infection 
prophylaxis in 15 children who had no outpatient follow-up.
DiSCuSSion
Burton et al.(9) studied 17 HIV-positive pregnant women and 
demonstrated that fetal infection is not correlated with placental 
infection when the immunohistochemistry with p24 antigen is 
applied, that is to say that there were cases in which the viral antigen 
was detected in the placenta and the child was not infected with 
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HIV-1 was characterized by the selection of the genotypic variant 
of the virus that is escaping the mother’s immune system. 
Kumar et al.(14) indicated in their research into the genetic 
sequencing of HIV-1 subtype C that the genomic differences in 
certain hydropathic and “Env” particle regions are associated 
with tropism for certain placental cells and, therefore, these gene 
mutations may be involved in vertical transmission.
Soilleux & Coleman(27), attempting to describe vertical 
transmission, studied binding lectins dendritic cell-specific ICAM- 
grabbing non- integrin (DC-SIGN), a receptor for HIV binding 
lectin that is expressed on the dendritic cell-specific ICAM- 
grabbing non- integrin. Boily-Larouche et al.(8) also investigated 
these viral DC-SIGN strains that underwent mutations and were 
linked with intrauterine infection.
The vertical transmission is correlated with viral load, 
symptomatology, co-infections and obstetric complications 
in HIV-positive pregnant women, according to data in the 
literature(15) and similarly corroborated by Zorrilla(32), who 
reported a higher incidence of coinfections that interfere in 
the vertical transmission. In our sample, we also observed co-
infections and obstetric complications in 22 patients (22/35-
62.9%), including in this total five patients who had transmitted 
the virus to their children.
As similarly reported by Baurakiades et al.(4), the analysis of 
our study did not allow us to identify any specific or abnormal 
macroscopic features of the placentas from HIV-positive pregnant 
women, inasmuch as the macroscopic changes were related to 
obstetric complications and maternal diseases.
According to Anderson(2), placentas exposed to HIV infection 
exhibited the following microscopic features: edema, villous 
immaturity, villous necrosis, focal necrosis of trophoblasts, 
numerous Hofbauer cells, excessive intervillous fibrin deposition 
and chorangiosis. However, these characteristics are not specific 
due to the fact that the patients were smokers, drug addicts 
and had coinfections, which may influence morphology of the 
placenta. We described the arteriopathy in the fetal circulation 
as the most frequent lesion in our cases (94%). Some authors 
also detected fetal vasculopathy in placentas from HIV-positive 
pregnant women(3, 23). We cannot assert that the observed 
vasculopathy is HIV specific, insofar as the patients were 
affected by other coinfections and diseases of different etiologies. 
Nevertheless, we may claim that HI, as other etiological 
agents, may be accountable for this lesion. The fact that 
immunopositivity for p24 antigen was evidenced in the villous 
capillary endothelium of one placenta from a mother who had 
no coinfection reinforces the idea that the virus is somehow 
responsible for this lesion, since the arteriopathy was observed in 
all five placentas from newborns who were HIV infected.
According to Bhoopat et al.(7), the histological evidence of 
HIV replication provided by p24 is found in approximately one 
quarter of the placentas obtained from full term pregnancies. 
Chorioamnionitis was also reported as a major risk factor for 
vertical transmission in 31 (86%) placentas. In our investigation, 
chorioamnionitis was identified in 31 (88.6%) placentas. The 
newborns were not infected in 15 of them and the mothers transmitted 
the virus to their children in 5 cases. Chandwani et al.(10) did not 
observe villitis, nor did they prove that chorioamnionitis may have 
been caused by HIV. However, in our material the immunopositivity 
for p24 antigen on the membranes was present in nine cases 
of chorioamnionitis, suggesting that the HIV was the cause of 
the inflammatory process. The decidua basalis, the intervillous 
space, the chorion of the chorionic plate and the umbilical cord 
may be involved in cases of chorioamnionitis depending on the 
severity and extent of the inflammatory process. Inflammation 
involving these structures in severe chorioamnionitis was found 
in our sample. We suggest the probable correlation of the HIV 
inflammatory process with these structures, which are detected 
in viral proteins by the immunohistochemistry method. The 
viral protein was identified in 14 cases of chorioamnionitis and 
5 placentas of newborns who had acquired HIV infection. We were 
not able to associate villitis exclusively with HIV, since infections 
such as syphilis, tuberculosis, infection by human papillomavirus 
(HPV), toxoplasmosis and urinary tract infection can also cause 
it. In four placentas from patients who had no coinfection during 
pregnancy, immunopositivity for p24 antigen associated with 
villitis was evidenced in Hofbauer cells from the villous stroma, 
in trophoblasts, in the intervillous space and in the endothelium 
of villous vessels, hence suggesting that villitis, intervillitis and 
vasculitis were caused by HIV. Therefore, there was vertical 
transmission in these cases. Shearer et al.(26) reported the presence 
of villitis in four cases out of 30 HIV-positive patients. Moreover, 
HIV in trophoblasts was detected by in situ PCR, thus corroborating 
the hypothesis of villitis by HIV.
Mwanyumba et al.(21) described nonspecific placental changes 
related to chronic hypoxia in HIV-positive patients. Herein these 
changes were observed in all placentas from infected children, 
who presented villous stromal edema, excess in syncytial knots and 
chorangiosis. These features were also attributed to hypertensive 
disorders of pregnancy, smoking, sickle cell disease and various 
infections. The stromal hypercellularity (immaturity) was detected 
in 30 cases (85.7%) from the total sample, and in all five cases 
of vertical transmission (Figure 4). Chandwani et al.(10) also 
reported the same incidence of villous immaturity in all cases of 
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vertical transmission of HIV-1. The hyalinization of villous stroma 
observed in 11 (31.4%) cases may be indicative of villitis repair 
process, since in these cases there was no evidence of fetal artery 
thrombosis or other causes of intrauterine hypoxia. This change 
was observed in two out of five placentas from children who had 
been infected. The villous immaturity identified in seven (20%) 
patients was correlated with prematurity and was evident in two 
out of five cases of vertical transmission, which demonstrates 
that this obstetric complication is an aggravating factor in this 
transmission. Landesman et al.(15) reported that children born 
before 32 weeks have twice the risk of being contaminated by the 
virus through vertical transmission.
Table 1 shows that the detection of viral antigen in the 
placenta did not always correspond with fetal infection in our 
sample, inasmuch as seven out of twelve cases in which the 
viral protein was detected were not infected with HIV. Vidricaire 
& Tremblay(31) showed that there are placental protective 
factors such as trophoblasts, in which the p24 viral particle is 
predominantly concentrated in their endosomal vesicles after 
the entry of HIV-1, thus determining low productive infection of 
various strains. According to Muñoz et al.(20), another placental 
protective factor is progesterone since it inhibits HIV-1 replication 
in placental cells by reducing TNF-α levels, which are required 
for replication. Al-Husaini(1) also demonstrated that placental 
infection does not imply fetal infection and established that IL-10 
produced by placental macrophages (Hofbauer cells) is a potent 
inhibitor of HIV-1 viral replication in these cells. Moreover, they 
act as reservoirs of the virus by blocking transmission to the fetus.
Baurakiades et al.(4) reported that the genetic structure of the 
virus strain is crucial for vertical transmission, showing that there 
is genotypic selection and less heterogeneity in its genetic makeup. 
Tripathi et al.(29) studied chemokine co-receptors CCR51 and 
CXCR7, indicating that certain features of the viral antigen can 
determine fetal infection. The authors claimed, therefore, that the 
detection of the placental viral protein is not enough. The presence 
of these molecular viral features is required to predict neonatal 
infection. 
Martin et al.(16) applied immunohistochemistry and yielded 
positive results in only four out of nine placentas from HIV-infected 
children. Herein, immunohistochemistry did not provide similar 
correlation between the detection of viral protein in placental 
tissue and neonatal infection, since this factor was negative in 
21 placentas and three from this total corresponded to children 
that had been infected. The probable causes of this negativity may 
account for the fact that the infection occurred in the perinatal 
period and antiretroviral medication had been applied.
Placentas from HIV-infected newborns showed viral protein near 
the vascular-fetal circulation. Accordingly, immunohistochemistry 
associated with histopathological study may aid the diagnosis of 
probable fetal infection. Nonetheless, the presence of the placental 
viral antigen is not a determinant predictive factor of fetal infection, 
as reported by Baurakiades et al.(4), who deployed in situ PCR to 
detect the location of viral antigen.
Sturt et al.(28) showed that the neonatal infection rates dropped 
to 1% to 2% due to vertical transmission prevention, mainly 
when the diagnosis is established during prenatal care. In our 
investigation, in the group of 21 women who were not medicated 
with AZT, immunohistochemistry revealed the viral protein in 
more cases (14/21, 52.3%), though there was no significant 
difference between the two groups according to the applied 
statistical test. The effectiveness of AZT prophylaxis in newborns 
was not confirmed in our study (Table 2).
Our anatomopathological and immunohistochemical 
analysis of the p24 virus particle contributed to the 
identification of the most common placental alterations in HIV 
+ pregnant women caused by transplacental viral infection, 
though it was not sufficient to determine fetal infection. The 
correlation with the aforementioned studies on the advances in 
molecular biology have enabled to verify that there is a higher 
sensitivity and specificity in molecular methods in terms of the 
host immune system, placental cells and the viral strain. Thus, 
complementary exams, namely molecular pathology methods 
such as PCR and viral gene sequencing of the viral genome, 
are required for a better understanding and diagnosis of fetal 
infection.
ConCLuSion
The most frequent placental lesions observed in our 
sample and in vertical transmission are arteriopathy in the 
fetal vascular circulation, chorioamnionitis, villous stromal 
hypercellularity, excessive syncytial knots, villous stromal edema 
and chorangiosis. These lesions are not specific to HIV or vertical 
transmission. The viral protein in the placenta was 67% lower 
in the cases under AZT treatment, but it was not possible to 
verify its effectiveness in the prevention of vertical transmission. 
The viral p24 antigen in placental tissue was not correlated 
with fetal infection. Our research revealed that it is possible to 
establish a definitive and early diagnosis of neonatal infection by 
histopathological examination of the placenta combined with 
immunohistochemistry for p24.
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rESuMo 
Introdução: A importância do estudo da placenta de gestantes com o vírus da imunodeficiência humana (HIV) soropositivas 
tornou-se alvo de inúmeros trabalhos na literatura. Aspectos morfológicos, virais, imunes e inflamatórios intrínsecos ao tecido 
placentário foram analisados para o entendimento da transmissão vertical do vírus. Objetivo: Identificar as lesões mais frequentes 
nas placentas, associando-as ao antígeno viral e correlacionando-as com a infecção dos recém-nascidos. Material e métodos: 
Trinta e cinco placentas de gestantes HIV soropositivas foram analisadas por estudo anatomopatológico e imuno-histoquímico, 
utilizando o anticorpo p24, no período de 1992 a 1997, segundo a rotina do laboratório do Serviço Anatomia Patológica/
Hospital Universitário Antônio Pedro/Universidade Federal Fluminense (SAP/HUAP/UFF). Resultados: As alterações microscópicas 
registradas em todos os casos, inclusive nos de transmissão vertical, foram arteriopatia no circuito vascular fetal, corionamnionite, 
depósito fibrinoide perivilositário, excesso de nós sinciciais, edema do estroma viloso e dismaturidade vilosa. Nenhuma alteração 
microscópica ou macroscópica específica do HIV foi encontrada nas placentas. A infecção neonatal pôde ser constatada em cinco 
casos. A transmissão vertical foi identificada em duas placentas entre cinco que tinham baixo peso para a idade gestacional. 
Análise da imuno-histoquímica do p24 mostrou 14 casos positivos, dois dos quais apresentaram transmissão vertical. A proteína 
viral não foi identificada em 10 das 14 placentas cujas pacientes foram medicadas com zidovudina (AZT). Conclusão: Nosso 
estudo contribuiu para o estudo anatomopatológico da placenta de pacientes soropositivas para o HIV, porém a expressão do p24 
por si só não permitiu um diagnóstico definitivo e precoce da transmissão vertical.
  
Unitermos: placenta; exame anatomopatológico; HIV; imuno-histoquímica; p24.
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